| MCISX | VFSAX | MCISX / VFSAX | |
| Total Expense Ratio | 2.10 | 0.16 | 1,313% |
| Annual Report Gross Expense Ratio | 3.49 | 0.16 | 2,181% |
| Fund Existence | 19 years | 7 years | - |
| Gain YTD | 11.645 | 9.718 | 120% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.71B | 14.3B | 33% |
| Annual Yield % from dividends | 0.89 | 2.95 | 30% |
| Returns for 1 year | 23.76 | 21.85 | 109% |
| Returns for 3 years | 60.40 | 45.47 | 133% |
| Returns for 5 years | 24.60 | 21.19 | 116% |
| Returns for 10 years | 112.83 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CTCSX | 61.39 | 1.06 | +1.76% |
| Calamos Timpani Small Cap Growth C | |||
| SVAAX | 7.04 | N/A | N/A |
| Federated Hermes Strategic Value Div A | |||
| FMPFX | 42.20 | N/A | N/A |
| Nuveen Small Cap Growth Opp R6 | |||
| LYFIX | 16.56 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare I | |||
| OGINX | 53.01 | N/A | N/A |
| Invesco Global Opportunities R | |||